BioSig Technologies (BSGM) Announces Proposed 2.5M Share Offering

BioSig Technologies, Inc. (NASDAQ: BSGM) today announced that it has agreed to sell 2,500,000 shares of its common stock, $0.001 par value per share, in a “best efforts” underwritten offering for gross proceeds of $10 million. The offering is expected to close on February 25, 2020, subject to customary closing conditions.

Laidlaw & Company (UK) Ltd. is acting as sole book-running manager for the offering.

BioSig intends to use the net proceeds from the offering to build product inventory, support organizational development to scale up our clinical and commercial operations, research and development of new products, fund filing of additional patent applications and prosecution of patents and for working capital and general corporate purposes.

You May Also Be Interested In

• Robinhood prices $2B convertible notes offering due 2029
• People Inc. names new chief accounting officer as predecessor retires
• Comfort Systems USA names new COO and Chief Strategy Officer